| Trial Identifier: | D7930C00005 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Parexel
|
| Start Date: | February 2025 |
| Primary Completion Date: | April 2025 |
| Study Completion Date: | April 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| US, MD | Brooklyn, MD, US, 21225 |